33 related articles for article (PubMed ID: 19109797)
1. Stroma AReactive Invasion Front Areas (SARIFA) predict poor survival in adenocarcinomas of the stomach and gastrooesophageal junction: a validation study.
Ulase D; Behrens HM; Röcken C
Virchows Arch; 2024 May; ():. PubMed ID: 38748262
[TBL] [Abstract][Full Text] [Related]
2. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
[TBL] [Abstract][Full Text] [Related]
3. IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer.
Huang W; Zhu L; Huang H; Li Y; Wang G; Zhang C
BMC Cancer; 2023 Feb; 23(1):116. PubMed ID: 36732736
[TBL] [Abstract][Full Text] [Related]
4. STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent.
Zhang X; Chen Q; He Y; Shi Q; Yin C; Xie Y; Yu H; Bao Y; Wang X; Tang C; Dong Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):19. PubMed ID: 36639675
[TBL] [Abstract][Full Text] [Related]
5. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
[TBL] [Abstract][Full Text] [Related]
6. IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype.
Köbel M; Xu H; Bourne PA; Spaulding BO; Shih IeM; Mao TL; Soslow RA; Ewanowich CA; Kalloger SE; Mehl E; Lee CH; Huntsman D; Gilks CB
Mod Pathol; 2009 Mar; 22(3):469-75. PubMed ID: 19136932
[TBL] [Abstract][Full Text] [Related]
7. Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer.
Chen HM; Lin CC; Chen WS; Jiang JK; Yang SH; Chang SC; Ho CL; Yang CC; Huang SC; Chao Y; Liao TT; Hwang WL; Teng HW
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203267
[TBL] [Abstract][Full Text] [Related]
8. The oncofetal protein IMP3 is an indicator of early recurrence and poor outcome in mucoepidermoid carcinoma of salivary glands.
Elshafey MR; Ahmed RA; Mourad MI; Gaballah ET
Cancer Biol Med; 2016 Jun; 13(2):286-95. PubMed ID: 27458536
[TBL] [Abstract][Full Text] [Related]
9. Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) as a Useful Immunohistochemical Marker for the Diagnosis of Adenocarcinoma of Small Intestine.
Daikuhara S; Uehara T; Higuchi K; Hosaka N; Iwaya M; Maruyama Y; Matsuda K; Arakura N; Tanaka E; Ota H
Acta Histochem Cytochem; 2015 Dec; 48(6):193-204. PubMed ID: 26855452
[TBL] [Abstract][Full Text] [Related]
10. Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.
Bi R; Shen X; Zhang W; Cheng Y; Feng Z; Cai X; Yang W
Diagn Pathol; 2016 Feb; 11():17. PubMed ID: 26837693
[TBL] [Abstract][Full Text] [Related]
11. Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.
Sheen YS; Liao YH; Lin MH; Chiu HC; Jee SH; Liau JY; Chang YL; Chu CY
PLoS One; 2016; 11(1):e0147431. PubMed ID: 26796627
[TBL] [Abstract][Full Text] [Related]
12. Expression of insulin-like growth factor-II mRNA-binding protein-3 as a marker for predicting clinical outcome in patients with esophageal squamous cell carcinoma.
Takata A; Takiguchi S; Okada K; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Mori M; Doki Y
Oncol Lett; 2014 Nov; 8(5):2027-2031. PubMed ID: 25295085
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma.
Lin L; Zhang J; Wang Y; Ju W; Ma Y; Li L; Chen L
Oncol Lett; 2013 Sep; 6(3):740-744. PubMed ID: 24137402
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
Bell JL; Wächter K; Mühleck B; Pazaitis N; Köhn M; Lederer M; Hüttelmaier S
Cell Mol Life Sci; 2013 Aug; 70(15):2657-75. PubMed ID: 23069990
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.
Lochhead P; Imamura Y; Morikawa T; Kuchiba A; Yamauchi M; Liao X; Qian ZR; Nishihara R; Wu K; Meyerhardt JA; Fuchs CS; Ogino S
Eur J Cancer; 2012 Dec; 48(18):3405-13. PubMed ID: 22840368
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-specific methylation of human genes in gastric cancer cells.
Ryan JL; Jones RJ; Kenney SC; Rivenbark AG; Tang W; Knight ER; Coleman WB; Gulley ML
Infect Agent Cancer; 2010 Dec; 5():27. PubMed ID: 21194482
[TBL] [Abstract][Full Text] [Related]
17. Analysis of IMP3 expression in normal and neoplastic human pituitary tissues.
Righi A; Zhang S; Jin L; Scheithauer BW; Kovacs K; Kovacs G; Goth MI; Korbonits M; Lloyd RV
Endocr Pathol; 2010 Mar; 21(1):25-31. PubMed ID: 19898970
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of insulin-like growth factor II mRNA-binding protein 3 expression in gastric adenocarcinoma.
Jeng YM; Wang TH; Lu SH; Yuan RH; Hsu HC
Br J Surg; 2009 Jan; 96(1):66-73. PubMed ID: 19109797
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
